Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02649686 | Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab | ||
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | ||
| NCT01344967 | Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect | ||
| NCT02032667 | Exercise Games and Physical Activity: Can a Home-based Exergame System Increase Physical Activity? | ||
| NCT00162929 | Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe) | ||
| NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | ||
| NCT02111239 | Preoperative Imaging in DIEP Flap Breast Reconstruction | ||
| NCT00005074 | Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma | ||
| NCT02353559 | Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia | ||
| NCT02033993 | Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen. | ||
| NCT05640999 | Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER | ||
| NCT06345079 | Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours | ||
| NCT06519682 | A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) | ||
| NCT03768570 | Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer | ||
| NCT02609373 | Improving Cancer-Related Outcomes in Shift Workers | ||
| NCT01627054 | A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT00387400 | Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme | ||
| NCT00372736 | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | ||
| NCT06686771 | Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer | ||
| NCT01916187 | Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma | ||
| NCT00658593 | Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | ||
| NCT07152821 | Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma | ||
| NCT03624543 | CFI-400945 in Patients With Advanced/Metastatic Breast Cancer | ||
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma | ||
| NCT03414970 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | ||
| NCT02974803 | Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases | ||
| NCT01259869 | A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression | ||
| NCT01237639 | Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation | ||
| NCT02502266 | Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer | ||
| NCT01144468 | Effects of Exemestane on Bone Strength | ||
| NCT04824014 | 4FMFES-PET Imaging of ER+ Advanced Breast Cancers | ||
| NCT02459301 | A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT00053794 | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | ||
| NCT05402124 | The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study | ||
| NCT00668707 | Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality | ||
| NCT02630693 | Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer | ||
| NCT00004234 | Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx | ||
| NCT00504296 | SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | ||
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | ||
| NCT02928575 | Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | ||
| NCT00197522 | Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | ||
| NCT00003653 | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | ||
| NCT00030875 | Bortezomib in Treating Patients With Mantle Cell Lymphoma | ||
| NCT03082495 | Exercise During and After Neoadjuvant Rectal Cancer Treatment | ||
| NCT00079066 | Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer | ||
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | ||
| NCT05920343 | VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy |
